medigraphic.com
SPANISH

Ginecología y Obstetricia de México

Federación Mexicana de Ginecología y Obstetricia, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number 09

<< Back Next >>

Ginecol Obstet Mex 2020; 88 (09)

Fetal cardiac tumor. Report of a case

Soto-López S, Arévalo-Martínez S, Carreras-Moratonas E, Ferrer-Menduiña Q
Full text How to cite this article

Language: Spanish
References: 21
Page: 638-643
PDF size: 213.33 Kb.


Key words:

Fetal cardiac tumors, Non immune fetal hydrops, Arrhythmias, pregnancy, Prenatal diagnosis, Echocardiography, Everolimus.

ABSTRACT

Background: Fetal cardiac tumors are rare, with a very low incidence, however; when they do occur, they are associated with life-threatening complications of the fetus. They are diagnosed from the second trimester and can cause non-immune fetal hydrops, arrhythmias, compression of outflow tracts, and sudden fetal death. Follow-up during pregnancy is important to detect possible complications and establish a birth plan.
Clinical case: A 35-year-old multigest patient, sent to the fetal maternal unit by his treating physician for evaluation for 24.2-week pregnancy and fetus with a single cardiac tumor, located on the apex, of large size; and without compromise in cardiac function, so only prenatal surveillance was warranted. At birth, the newborn received everolimus treatment, with a good response.
Conclusion: The case of a patient with a single pregnancy and fetus with a prenatal diagnosis of a large cardiac tumor is presented with a family history of hemangiomas. In this case, a follow-up approach to detect prenatal complications and establish a birth plan in a third level of medical care is critical for a good practice.


REFERENCES

  1. Isaacs H. Fetal and Neonatal cardiac tumor. Pediatr Cardiol 2004; 25: 252-73. doi: 10.1007/S00246-003-0590-4.

  2. Geipel A, et al. Perinatal diagnosis of cardiac tumors. Ultrasound Obstet Gynecol 2001; 17: 17-21. https://doi. org/10.1046/j.1469-0705.2001.00314.x

  3. Baird C, et al. Right atrial hemangioma in the newborn: Utility of fetal imaging. Ann Pediatr Cardiol 2012; 5 (1): 81-84. doi: 10.4103/0974-2069.93719.

  4. Yuan S. Fetal primary cardiac tumors during perinatal period. Pediatrics and neonatology 2017; 58: 205-10. http:// dx.doi.org/10.1016/j.pedneo.2016.07.004.

  5. Holley D, et al. Diagnosis and management of fetal cardiac tumors: A multicenter experience and review of published reports. J Am Coll Cardiol 1995; 26 (2): 516-20. https://doi. org/10.1016/0735-1097(95)80031-B.

  6. Yates J. Tuberous sclerosis. Eur J Hum Gen 2006; 14: 106- 173. doi: 10.1038/sj.ejhg.5201625.

  7. Bader R, et al. Fetal rhabdomyoma: prenatal diagnosis, clinical outcome and incidence of associated tuberous sclerosis complex. J Pediatr 2003; 143: 620-4. doi: https:// doi.org/10.1067/S0022-3476(03)00494-3.

  8. Northrup H, Krueger D. Tuberous sclerosis complex diagnostic criteria update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatric Neurology 2012; 49: 243-54. doi: 10.1016/j.pediatrneurol.2013.08.001.

  9. Das B, Sharma J. Cardiac Rhabdomyoma and tuberous sclerosis: prenatal diagnosis and follow-up. Indian J Pediat 2003; 70 (1): 87-89. doi: 10.1007/bf02722750.

  10. Milunsky A, et al. Prenatal molecular diagnosis of tuberous sclerosis complex. Am J Obstet Gynecol 2009; 200: 321. e1-321.e6. doi: 10.1016/j.ajog.2008.11.004.

  11. Demir A, et al. Everolimus: A Challenging drug in the treatment of multifocal inoperable cardiac rhabdomyoma. Pediatrics 2012; 130: e243-e247. https://doi.org/10.1542/ peds.2011-3476.

  12. Nair A, et al. Spontaneous regression of a gigantic cardiac rhabdomyoma. Heart Lung Circ 2017; 26 (11) e105-e106. doi: 10.1016/j.hlc.2017.02.019.

  13. Hoshal S, et al. Regression of massive cardiac rhabdomyoma on everolimus therapy. Pediatr Int 2016; 58 (5): 397-99. https://doi.org/10.1111/ped.12816.

  14. Uzun O, et al. Cardiac tumours in children. Orphan J Rare Dis 2007; 2: 1-14. doi: 10.1186/1750-1172-2-11.

  15. Leithiser R, et al. Prenatal sonographic diagnosis of atrial hemangioma. AJR Am J Roentgenol 1988; 147: 1207-8. doi: 10.2214/ajr.147.6.1207.

  16. Li W, et al. Cardiac hemangioma: A comprehensive analysis of 200 cases. Ann Thorac Surg 2015; 99: 2246-52. https:// doi.org/10.1016/j.athoracsur.2015.02.064.

  17. Lacey S, et al. Fetal cardiac tumors: prenatal diagnosis and outcome. Pediatr Cardiol. 2007; 28: 61-67. https://doi. org/10.1007/s00246-005-0876-9.

  18. Dennis M, et al. The echocardiographic diagnosis of multiple fetal cardiac tumors. J Ultrasound Med. 1985; 4: 327-329. doi: 10.7863/jum.1985.4.6.327.

  19. Gu X, et al. Antenatal screening and diagnosis of tuberous sclerosis complex by fetal echocardiography and targeted genomic sequencing. Medicine 2018; 97: 15 (e0112). http://dx.doi.org/10.1097/MD.0000000000010112.

  20. Gresser C, et al. Fetal cardiac tumor: A prenatal echocardiographic marker for tuberous sclerosis. Am J Obstet Gynecol 1987; 156: 689-90. https://doi.org/10.1016/0002- 9378(87)90079-2.

  21. Zhou Q, et al. Prenatal echocardiographic differential diagnosis of fetal cardiac tumors. Ultrasound Obstet Gynecol 2004; 23: 165-71. doi: 10.1002/uog.979




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ginecol Obstet Mex. 2020;88